Larson Financial Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4K | Buy |
843
+8
| +1% | +$137 | ﹤0.01% | 1633 |
|
|
2025
Q1 | $53.3K | Sell |
835
-7,916
| -90% | -$505K | ﹤0.01% | 999 |
|
|
2024
Q4 | $1.06M | Buy |
8,751
+2
| +0% | +$243 | 0.06% | 231 |
|
|
2024
Q3 | $1.09M | Buy |
8,749
+8,249
| +1,650% | +$1.03M | 0.06% | 215 |
|
|
2024
Q2 | $79K | Hold |
500
| – | – | 0.01% | 703 |
|
|
2024
Q1 | $64.7K | Hold |
500
| – | – | 0.01% | 633 |
|
|
2023
Q4 | $48.2K | Sell |
500
-9
| -2% | -$868 | ﹤0.01% | 657 |
|
|
2023
Q3 | $61.7K | Buy |
509
+9
| +2% | +$1.09K | 0.01% | 556 |
|
|
2023
Q2 | $57.3K | Hold |
500
| – | – | 0.01% | 528 |
|
|
2023
Q1 | $68.9K | Hold |
500
| – | – | 0.01% | 486 |
|
|
2022
Q4 | $64.8K | Hold |
500
| – | – | 0.01% | 474 |
|
|
2022
Q3 | $55K | Hold |
500
| – | – | 0.01% | 455 |
|
|
2022
Q2 | $37K | Hold |
500
| – | – | 0.01% | 434 |
|
|
2022
Q1 | $39K | Hold |
500
| – | – | 0.01% | 417 |
|
|
2021
Q4 | $45K | Hold |
500
| – | – | 0.01% | 398 |
|
|
2021
Q3 | $46K | Hold |
500
| – | – | 0.01% | 314 |
|
|
2021
Q2 | $39K | Hold |
500
| – | – | 0.01% | 314 |
|
|
2021
Q1 | $37K | Hold |
500
| – | – | 0.01% | 302 |
|
|
2020
Q4 | $85K | Hold |
500
| – | – | 0.03% | 153 |
|
|
2020
Q3 | $70K | Hold |
500
| – | – | 0.03% | 159 |
|
|
2020
Q2 | $80K | Hold |
500
| – | – | 0.04% | 147 |
|
|
2020
Q1 | $49K | Hold |
500
| – | – | 0.03% | 159 |
|
|
2019
Q4 | $65K | Hold |
500
| – | – | 0.04% | 132 |
|
|
2019
Q3 | $38K | Hold |
500
| – | – | 0.02% | 171 |
|
|
2019
Q2 | $76K | Hold |
500
| – | – | 0.06% | 100 |
|
|
2019
Q1 | $60K | Hold |
500
| – | – | 0.05% | 101 |
|
|
2018
Q4 | $55K | Buy |
+500
| New | +$55K | 0.05% | 107 |
|